Summary
Long-term administration of ciclosporin has been complicated by side-effects, the predominant being nephrotoxicity. We performed renal function studies on 20 patients treated with ciclosporin (group 1) and on 12 patients serving as controls (group 2). Only patients with serum creatinine less than 1.3 mg/dl entered the study. The renal function studies consisted of: Inulin clearance, PAH clearance, sodium sulphate loading, sodium bicarbonate loading. Plasma renin activity (PRA), inactive renin (IR) and aldosterone (ALDO) were measured basally and after stimulation with 40 mg furosemide i.v. Serum creatinine was not significantly impaired under ciclosporin with 1.1±0.1 mg/dl vs 0.9±0.1 mg/dl in the control group (ns). Glomerular filtration rates as measured by creatinine and inulin clearance were significantly impaired in group 1 as compared to group 2. Inulin clearance was impaired by ciclosporin with 93.5±4.4 ml/min/1.73m2 as compared to 121±6.6 ml/min/1.73 m2 (p<0.05) in patients of group 2. The PAH clearance in ciclosporin treated patients was impaired, with 379±22.1 ml/min/1.73 m2 in group 1 as compared to 605±39 ml/min/1.73 m2 (p<0.001) in group 2. Mean arterial pressure and renovascular resistance were significantly increased in ciclosporin treated patients. We demonstrated, by means of sodium sulphate and bicarbonate loading, incomplete distal tubular acidosis in 3 patients from group 1 but in none of group 2. There was no difference in basal plasma renin activity (PRA), but during volume contraction induced by furosemide there was only blunted response by PRA in patients receiving ciclosporin with 2.7±0.3 ng/ml/h as compared to 7.7±0.5 ng/ml/h in controls. Inactive renin was significantly increased during administration of ciclosporin and did not respond to volume contraction. Ciclosporin induced a significant impairment of renal perfusion and glomerular filtration and an increased mean arterial pressure and renovascular resistance. The decreased PRA may be due to an impaired conversion of inactive to active renin. It is possible, using appropriate methods, to prove that ciclosporin induced nephrotoxicity is also located to the distal tubular segment.
Similar content being viewed by others
Abbreviations
- ALDO:
-
Aldosteron
- F:
-
Furosemid
- IR:
-
Inaktives Renin
- MAP:
-
Mittlerer arterielle Blutdruck
- NAE:
-
Nettosäureausscheidung
- PRA:
-
plasma renin activity, Plasmareninaktivität
- RAA:
-
Renin-Angiotensin-Aldosteron-System
- RIA:
-
Radioimmunoassay
- RTA I:
-
distale tubuläre Azidose
- RVR:
-
renovaskulärer Widerstand
- TA:
-
titrierbare Azidität
Literatur
Adu D, Turney J, Michael J, McMaster P (1983) Hyperkalemia in cyclosporine treated renal allograft recipients. Lancet II:370–372
Ballarin J, Sola R, Eagliardi B, Yanez C, Daponte R, Donate T, Vila R, Castellet R, del Rio G (1988) Effect of cyclosporine A on urinary acidification. Proceedings Xth International Congress of Nephrology, London, p 608
Bantle JP, Boudreau J, Ferris TF (1987) Suppression of plasma renin activity by cyclosporine A. Am J Med 83:39–45
Batlle DC, Guttermann G, Tarka J, Prasad R (1986) Effect of short term Cyclosporine A administration on urinary acidification. Clin Nephrol 25 [Suppl 1]:62–69
Bryer Ash M, Fraze EB, Luetscher JA (1988) Plasma renin and prorenin in diabetes mellitus. Effects of intravenous furosemide. J Clin Endocrinol Metab 66:454–458
Cole BR, Giangiacomo J, Inglefinger JR, Robson AM (1972) Measurement of renal function without urine collection: A critical evaluation of the constant infusion technique for determination of inulin and paraaminohippurate. N Engl J Med 287:1109–1114
Cunnarro JA, Weiner WM (1977) A comparison of methods for measuring urinary ammonium. Kidney Int 2:357–365
Curtis JJ, Luke RG, Dubrovsk E, Diethelm AG, Whelchel JD, Jones P (1986) Cyclosporine in therapeutic doses increases renal allograft vascular resistance. Lancet II:477–479
Curtis JJ, Luke RG, Jones P, Diethelm AG (1988) Hypertension in cyclosporine treated renal transplant recipient is sodium dependant. Am J Med 85:134–138
Dougados M, Amor B (1987) Cyclosporine A in rheumatoid arthritis: preliminary results of an open trial. Arthritis Rheum 30:11–17
Gonick HC, Buckalew VM (1985) Renal tubular disorders. Marcel Decker, New York Basel
Halperin ML, Goldstein M, Haig A, Johnson MD, Stinebaugh BJ (1974) Studies on the pathogenesis of type 1 (distal) renal tubular acidosis as revealed by the urinary CO2 tensions. J Clin Invest 53:669–677
Hamilton DV, Evans DB, Henderson RG, Thiru S, Calne R (1981) Nephrotoxicity and metabolic acidosis in transplant patients on cyclosporin A. Proc Eur Dial Transplant Assoc 18:400–407
Heering P, Westhoff A, Bach D, Sprenger KBG, Passlick J, Helmchen U, Grabensee B (1988) Renin-Aldosterone System and renal function under cyclosporine A. Transplant Proc 20 (Suppl 3):556–562
Heering P, Grabensee B (1990) Ist die niedrig dosierte Therapie mit Cyclosporin A weniger nephrotoxisch? Klin Wochenschr (Suppl XIX) 68:70
Heering P, Grabensee B (1991) The influence of Cyclosporine A on renal tubular function after kidney transplantation. Nephron (im Druck)
Heering P, Grabensee B (im Druck) Die Inulin- und PAH-Clearance in der Diagnostik chronischer Nierenerkrankungen. Zeitschrift für Nieren- und Hochdruckkrankheiten
Helmchen U, Kneissler U, Gebauer W, Rohland C, Gröne HJ (1986) Renin und juxtaglomerulärer Apparat bei Goldblatt Ratten unter Einfluß von CyA. Z Nieren-Hochdruckkr 15:380
Kutkuhn B, Chlebowski H, Hollenbeck M, Grabensee B (1989) Untersuchung zur Konversion von inaktivem Renin zu aktivem Renin nach akuter ACE-Hemmung bei essentieller Hypertonie und renovaskulärer Hypertonie. Z Kardiol 78:204–210
Kurtzmann N (1983) Acquired distal renal tubular acidosis. Kidney Int 24:807
Levey AS, Madaio MP, Perrone RD (1991) Laboratory assessment of renal disease: Clearance, Urinalysis and renal biopsy. In: Brenner B, Rector FC (Eds) The Kidney. Saunders, Philadelphia
Lin S, Chan J (1973) Urinary bicarbonate — a titrimetric method for determination. Clin Biochem 6:207–210
Löllgen H (1983) Kardiopulmonale Funktionsdiagnostik. Ciba Geigy, Wehr/Baden
Loughran TP, Deeg HJ, Dahibuy S, Kennedy MS, Starb R, Thomas ED (1985) Incidence of hypertension after marrow transplantat among 112 patients randomized to either cyclosporine or methotrexate as graft versus host disease prophylaxis. Br J Haematol 59:547
Mason J (1990) The pathophysiology of Sandimmune in men and animals. Pediatr Nephrol 4:554–574
Myers BD, Sibley R, Newton L, Tomlanovich S, Boskos C, Stinson E, Luetscher JA, Whitney DJ, Krasny D, Coplon NS, Perlroth MG (1988) The long term course of cyclosporine associated chronic nephropathy. Kidney Int 33:590–600
Myers BD, Newton L, Boskos C, Makoviak JA, Frist WH, Derby GC, Perlroth MG, Sibley RK (1988) Chronic injury of human renal microvessels with low dose cyclosporine therapy. Transplantation 46:694–703
Palestine AG, Nussenblatt RB, Chan CC (1984) Side effects of cyclosporine in nontransplant patients. Am J Med 77:652–656
Porter GA, Bennett W, Sheldon G, Sheps MD (1990) Cyclosporin A associated hypertension. Arch Int Med 150:280
Schnurr E, Lahme W, Küppers H (1980) Measurement of renal clearance of inulin and PAH in the stady state without urine collection. Clin Nephrol 13/1:26–29
Schollmeyer P (1982) Erworbene Tubulopathien. In: Losse H, Renner E (Hrsg) Klinische Nephrologie. Thieme, Stuttgart New York
Shemesh O, Golbertz H, Kriss JP, Myers BD (1985) Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28:830–838
Seldin DW, Colman AJ, Carter N, Rector FC (1967) The effect of Na2SO4 on urinary acidification in chronic renal disease. J Lab Clin Med 69:893–903
Stahl RAK, Kanz L, Maier B, Schollmeyer P (1986) Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine A associated side effect. Clin Nephrol 25:245–248
Tan SY, Antonipillai I, Mulrow P (1980) Inactive renin and prostaglandin E2 production in hyporeninemic hypoaldosteronism. J Clin Endocrinol Metab 51:849–853
Tejani A, Butt K, Trachtmann H (1988) CyA induced remission of relapsing nephrotic syndrome in children. Kidney Int 63:729–734
Tindall RS, Rollins JA, Phillips JT, Greenlee RG, Wells L, Belendiuk G (1987) Preliminary results of a double blind, randomized placebo controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 316:719–724
Versluis DJ, Wenting GJ, Jeekel J, Weimar W (1988) The influence of cyclosporine on proximal tubular function in renal allografts. Transplant Proc 20 (Suppl 3):686–690
Wilson D, Luetscher JA (1990) Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med 323:1101–1106
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heering, P., Kutkuhn, B., Kreuzpaintner, G. et al. Untersuchungen zur Nierenfunktion nierengesunder Patienten unter Ciclosporin. Klin Wochenschr 69, 880–886 (1991). https://doi.org/10.1007/BF01649562
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01649562